Champions Oncology Inc

CSBRNASDAQ · USD
4.70USD0.00 (+1.19%)
255

Champions Oncology Inc (CSBR) Historical Volatility

CSBR's 30 day historical volatility is 26.11%, in the 6th percentile of readings over the past year. This is a low percentile, meaning Champions Oncology Inc shares have been calmer than usual. CSBR's 30 day implied volatility sits at 292.55%, with an IV Rank of 78.57%, leaving IV 266.44 points above historical volatility. This means options are pricing in more movement than the stock has actually delivered, as of Nov 13, 2026.

Read more

Tracking CSBR historical volatility helps you see how much Champions Oncology Inc's stock price has actually moved, giving you a baseline for whether option premiums look fair, cheap, or expensive. While implied volatility shows what the market expects, CSBR's HV, also known as realized volatility, shows what actually happened. Use our scanner to monitor CSBR 30 day historical volatility alongside longer lookback windows and spot the moments when realized and implied diverge.

Historical volatility is the annualized standard deviation of a stock's past returns, typically measured over rolling windows like 10, 20, 30, or 60 days. CSBR's 30 day historical volatility, or CSBR HV, is one of the most widely watched readings because it balances responsiveness with stability. Comparing CSBR's HV to its implied volatility reveals the volatility risk premium. When IV sits well above HV, options are pricing in more movement than the stock has actually delivered, giving option sellers an edge. When HV runs hot relative to IV, options are pricing in less movement than the stock has delivered, and buyers may be underpaying for it.

Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process.

Historical Volatility

HV Percentile
6thHV Percentile
Low

Historical movement is subdued versus the past year. The stock has been unusually quiet.

Historical Volatility (30d)26.11%

HV Percentile6th

Implied Volatility (30d)292.55%

IV Rank78.57%

IV Minus HV+266.44%

As of Nov 13, 2026

IV vs HV
Implied Volatility (IV) vs Historical Volatility (HV) over the past month.

As of Nov 13, 2026

IV - HV Difference
Difference between IV and HV over time. Positive values indicate IV > HV.

As of Nov 13, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →